Clinical Trials on Peritoneal Dialysis Catheter Exit Site Infection in Australia

Total 4 results

  • The University of Queensland
    The HOME Network; Australia and New Zealand Dialysis and Transplant Registry; New Zealand Peritoneal Dialysis Registry
    Recruiting
    Targeted Education ApproaCH to Improve Peritoneal Dialysis Outcomes Trial (TEACH-PD)
    Kidney Disease, Chronic | Peritoneal Dialysis Catheter Exit Site Infection | Peritoneal Dialysis Catheter-Associated Peritonitis | Peritoneal Dialysis Catheter Tunnel Infection
    Australia, New Zealand
  • Sir Charles Gairdner Hospital
    The University of Western Australia
    Terminated
    The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients
    Peritoneal Dialysis | Peritoneal Dialysis, Continuous Ambulatory
    Australia
  • The University of Queensland
    Queensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaborators
    Recruiting
    Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) (ProP)
    Wound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site Reactions
    Australia, France
  • Medicenna Therapeutics, Inc.
    Merck Sharp & Dohme LLC
    Recruiting
    A Beta-only IL-2 ImmunoTherapY Study (ABILITY-1)
    Clear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Primary Peritoneal Cancer | Endometrial Carcinoma and other conditions
    United States, Australia, Korea, Republic of, Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe